PROSER2 and cancer: Furthermore, PROSER2 has been identified asa potential biomarker in epithelial cell, breast, prostate, ovarian,lung, brain, and hematological cancers.12,13 It is highlyexpressed in both benign and malignant bone tumors and is consideredto be a factor in poor prognosis.